BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35682789)

  • 1. Oral Fibrosis and Oral Cancer: From Molecular Targets to Therapeutics.
    Hsieh PL; Yu CC
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear Blebbing Frequency in Tobacco-Induced Oral Potentially Malignant Disorders: A Pilot Study.
    Yadahalli R; Kheur S; Adwani A; Bhonde R; Raj AT; Patil S
    Acta Cytol; 2021; 65(5):403-410. PubMed ID: 34120116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmented mRNA expression of tissue inhibitor of metalloproteinase-1 in buccal mucosal fibroblasts by arecoline and safrole as a possible pathogenesis for oral submucous fibrosis.
    Shieh DH; Chiang LC; Shieh TY
    Oral Oncol; 2003 Oct; 39(7):728-35. PubMed ID: 12907213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of epithelial-mesenchymal transition in oral squamous cell carcinoma and oral submucous fibrosis.
    Yanjia H; Xinchun J
    Clin Chim Acta; 2007 Aug; 383(1-2):51-6. PubMed ID: 17537414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral submucous fibrosis: An enigmatic morpho-insight.
    Hande AH; Chaudhary MS; Gawande MN; Gadbail AR; Zade PR; Bajaj S; Patil SK; Tekade S
    J Cancer Res Ther; 2019; 15(3):463-469. PubMed ID: 31169205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphometric analysis of spinous cell in oral submucous fibrosis. Comparison with normal mucosa, leukoplakia and squamous cell carcinoma.
    Gao S; Liu S; Shen Z; Peng L
    Chin Med J (Engl); 1995 May; 108(5):351-4. PubMed ID: 7555236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral submucous fibrosis: a clinicopathologic review of 205 cases in Indians.
    Angadi PV; Rekha KP
    Oral Maxillofac Surg; 2011 Mar; 15(1):15-9. PubMed ID: 20414694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral Submucous Fibrosis as an Overhealing Wound: Implications in Malignant Transformation.
    Sharma M; Shetty SS; Radhakrishnan R
    Recent Pat Anticancer Drug Discov; 2018; 13(3):272-291. PubMed ID: 29485009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of oral submucous fibrosis. Relationship to risk factors associated with oral cancer.
    Pillai R; Balaram P; Reddiar KS
    Cancer; 1992 Apr; 69(8):2011-20. PubMed ID: 1544110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the pattern of copper as an etiological factor in oral submucous fibrosis: a cytological study.
    Sharma A; Sahni P; Nayak MT; Singhvi A; Kumar R
    J Exp Ther Oncol; 2014; 10(4):317-23. PubMed ID: 25509987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral submucous fibrosis: etiology, pathogenesis, and future research.
    Rajendran R
    Bull World Health Organ; 1994; 72(6):985-96. PubMed ID: 7867145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral submucous fibrosis--a potentially malignant condition of growing concern.
    Mahomed F
    SADJ; 2012 Nov; 67(10):562, 564-5. PubMed ID: 23957096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA content abnormality in oral submucous fibrosis concomitant leukoplakia: A preliminary evaluation of the diagnostic and clinical implications.
    Xiao X; Hu Y; Li C; Shi L; Liu W
    Diagn Cytopathol; 2020 Nov; 48(11):1111-1114. PubMed ID: 32433822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo autofluorescence characteristics of pre- and post-treated oral submucous fibrosis: a pilot study.
    Vedeswari CP; Jayachandran S; Ganesan S
    Indian J Dent Res; 2009; 20(3):261-7. PubMed ID: 19884705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of oral submucous fibrosis by collagenase: effects on oral opening and eating function.
    Lin HJ; Lin JC
    Oral Dis; 2007 Jul; 13(4):407-13. PubMed ID: 17577328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral submucous fibrosis in a young patient.
    Yazdanpanah MJ; Banihashemi M; Pezeshkpoor F; Famili S; Layegh P; Katebi M; Hamidi H
    Acta Dermatovenerol Alp Pannonica Adriat; 2009 Dec; 18(4):176-8. PubMed ID: 20043056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of oral mucosal stem cell markers in oral submucous fibrosis and their reactivation in malignant transformation.
    Sharma M; Fonseca FP; Hunter KD; Radhakrishnan R
    Int J Oral Sci; 2020 Aug; 12(1):23. PubMed ID: 32826859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Squamous cell carcinoma of the oral mucosa after release of submucous fibrosis and bilateral small radial forearm flap reconstruction.
    Celik N; Wei FC; Chang YM; Yang WG; Chen DJ; Tsai CY
    Plast Reconstr Surg; 2002 Jul; 110(1):34-8. PubMed ID: 12087228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral squamous cell carcinoma arising in background of oral submucous fibrosis: a clinicopathologically distinct disease.
    Chaturvedi P; Vaishampayan SS; Nair S; Nair D; Agarwal JP; Kane SV; Pawar P; Datta S
    Head Neck; 2013 Oct; 35(10):1404-9. PubMed ID: 22972608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Appearance of a primary in a case of 'carcinoma unkown primary' with advanced oral submucous fibrosis.
    Merchant YP; Shetty S; Kudpaje AS; Rao VUS
    Oral Oncol; 2020 Oct; 109():104716. PubMed ID: 32305311
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.